HIV prevention in women: next steps.
Sten H
SH
Vermund
Lut
L
Van Damme
D000225:Adenine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000282:Administration, Intravaginal; D019380:Anti-HIV Agents / Q000008:administration & dosage*; D017326:Clinical Trials, Phase III as Topic; D003075:Coitus; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D063065:Organophosphonates / Q000008:administration & dosage*; D000068698:Tenofovir; D014622:Vaginal Creams, Foams, and Jellies
D019380:Anti-HIV Agents; D063065:Organophosphonates; D014622:Vaginal Creams, Foams, and Jellies; D000068698:Tenofovir; D000225:Adenine